Nascent Pharma Holdings succeeds Can B Corp. as public holding company via stock-for-stock merger

Nascent Pharma Holdings, Inc.

Each share of Can B common and preferred converted 1:1 into equivalent Nascent share; no stockholder vote required.
Outstanding shares: 71,239,311 common, 5 Series A, 1,100 Series C, 4,000 Series D preferred; all classes unchanged.
Same board and officers continue: Marco Alfonsi (CEO), Stanley L. Teeple (CFO, Secretary).
Nascent adopted a Code of Business Conduct and Ethics and an Incentive Stock Option Plan.
New trading symbol not yet assigned; FINRA processing pending.

item 1.01 item 3.03 item 5.03 item 5.02 item 5.05 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Nascent Pharma Holdings, Inc.: Adopted new Articles of Incorporation substantially identical to prior Can B articles except for name change (effective 2024-09-13).

Change: charter amendment
Effective: 2024-09-13

Exact text from the filing

The Nascent Articles of Incorporation were filed with the Florida Secretary of State on September 13, 2024.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Nascent Pharma Holdings, Inc.: Adopted new Bylaws substantially identical to prior Can B bylaws except for name change.

Change: bylaw amendment

Exact text from the filing

adopted the Bylaws of Nascent (the “ Nascent Bylaws ”) that each contains provisions substantially identical to those of Can B immediately prior to the consummation of the Nascent Merger, except for the change of the name of the corporation

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Nascent Pharma Holdings, Inc.: Adopted a Code of Business Conduct and Ethics (effective 2024-10-24).

Change: code of ethics
Effective: 2024-10-24

Exact text from the filing

On October 24, 2024, Nascent adopted a Code of Business Conduct and Ethics (the “ Code ”) that was approved by the Board of Directors on October 25, 2024

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001493152-24-042727

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.